All stock lists
MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
Healthcare · Biotechnology
7.77-0.20 (-2.47%)
Insider Score
––Not scored
MPLT Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
MPLT analyst forecast
MPLT analyst consensus
No analyst ratings in the last 3 months.
MPLT 12-month price target
$32.33+319.9% upsideaverage of 9 firms
$48.00High
$21.00Low
Best analysts covering MPLT
No firm covering MPLT has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
MPLT analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Needham | — | $43.00 | +241.3% | — | 2026-08-31 | |
| Canaccord Genuity | — | $21.00 | +80.6% | — | 2026-08-14 | |
| Craig-Hallum | — | $25.00 | +144.9% | — | 2026-07-28 | |
| Canaccord Genuity | — | $24.00 | +142.3% | — | 2026-07-28 | |
| H.C. Wainwright | — | $26.00 | +162.5% | — | 2026-07-28 | |
| Wolfe Research | — | $30.00 | +202.9% | — | 2026-07-27 | |
| Canaccord Genuity | — | $43.00 | +22.1% | — | 2026-07-24 | |
| Stifel Nicolaus | — | $36.00 | +21.0% | — | 2026-06-01 | |
| UBS | — | $48.00 | +62.9% | — | 2026-05-26 | |
| Craig-Hallum | — | $43.00 | +54.6% | — | 2026-05-21 | |
| H.C. Wainwright | — | $45.00 | +46.6% | — | 2026-05-04 | |
| Leerink Partners | — | $30.00 | +125.7% | — | 2025-11-21 | |
| Jefferies | — | $32.00 | +140.8% | — | 2025-11-21 |
MPLT earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-05-15 | -1.05 | -1.34 | $0 | $0 |
| 2026-08-13 | -1.35 | -1.32 | $0 | $0 |
| 2026-09-18 | -1.35 | -1.32 | $0 | $0 |
| 2026-12-03 | -1.22 | 0.00 | $0 | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.